Nilotinib attenuates vascular pathology in experimental cerebral malaria
Abstract: Cerebral malaria (CM), a life-threatening complication of Plasmodium falciparum infection, is characterized by the sequestration of infected erythrocytes in the brain microvasculature. Our study investigated the potential of repurposing tyrosine kinase inhibitors targeting BCR-ABL1 (BCR-AB...
Saved in:
| Main Authors: | Luana S. Ortolan, Priyanka Bansal, Veronica I. Primavera, Rodrigo J. R. X. Freitas, Ling Wei, Sabrina Epiphanio, Alexis Kaushansky, Joseph D. Smith |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Blood Advances |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952925001296 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond expectations: investigating nilotinib’s potential in attenuating neurodegeneration in Alzheimer’s disease
by: Darcy Tocci, et al.
Published: (2025-03-01) -
Nilotinib-Associated Destructive Thyroiditis
by: Suhalia Bakerywala, et al.
Published: (2015-01-01) -
Association of Heme Oxygenase 1 with Lung Protection in Malaria-Associated ALI/ARDS
by: Marcelo L. M. Pereira, et al.
Published: (2016-01-01) -
CEREBRAL VASCULAR PATHOLOGY IN RHEUMATIC DISEASES
by: N. V. Pizova, et al.
Published: (2001-10-01) -
Nilotinib - new step of success in CML therapy
by: E. G. Lomaia, et al.
Published: (2022-11-01)